tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BCAB Stock Latest News

BioAtla announces poster presentations at 2025 AACR meeting
The FlyBioAtla announces poster presentations at 2025 AACR meeting
10d ago
BCAB
BioAtla price target lowered to $1 from $5 at Citizens JMP
PremiumThe Fly
BioAtla price target lowered to $1 from $5 at Citizens JMP
1M ago
BCAB
BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook
PremiumCompany Announcements
BioAtla’s Earnings Call: Clinical Progress and Strategic Outlook
1M ago
BCAB
Positive Outlook for BioAtla: Strategic Moves and Promising Developments Signal Potential Upside
PremiumRatings
Positive Outlook for BioAtla: Strategic Moves and Promising Developments Signal Potential Upside
1M ago
BCAB
BioAtla price target lowered to $10 from $13 at BTIG
PremiumThe Fly
BioAtla price target lowered to $10 from $13 at BTIG
1M ago
BCAB
BioAtla, Inc. Reports 2024 Financial Results and Clinical Progress
PremiumCompany AnnouncementsBioAtla, Inc. Reports 2024 Financial Results and Clinical Progress
1M ago
BCAB
BioAtla announces restructuring, to cut over 30% of workforce
Premium
The Fly
BioAtla announces restructuring, to cut over 30% of workforce
1M ago
BCAB
BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year
Premium
The Fly
BioAtla reports Q4 Net loss ($14.9M) vs ($26.9M) last year
1M ago
BCAB
BCAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BCAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
BCAB
BioAtla Awards Executive Bonuses and Stock Units
PremiumCompany Announcements
BioAtla Awards Executive Bonuses and Stock Units
2M ago
8K
BCAB
BioAtla Secures $9.2M for Clinical Program Advancements
PremiumCompany Announcements
BioAtla Secures $9.2M for Clinical Program Advancements
4M ago
8K
BCAB
BioAtla Highlights Advancements in CAB Cancer Therapy
PremiumCompany Announcements
BioAtla Highlights Advancements in CAB Cancer Therapy
4M ago
8K
BCAB
BioAtla to sell 9.68M shares at 95.2c in registered direct offering
PremiumThe FlyBioAtla to sell 9.68M shares at 95.2c in registered direct offering
4M ago
BCAB
BioAtla presents data on mecbotamab vedotin in advanced NSCLC
Premium
The Fly
BioAtla presents data on mecbotamab vedotin in advanced NSCLC
5M ago
BCAB
Michael Burry Boosts His Bet on Chinese Stocks in Q3
Premium
Market News
Michael Burry Boosts His Bet on Chinese Stocks in Q3
6M ago
JD
HPP
BioAtla downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
BioAtla downgraded to Neutral from Buy at H.C. Wainwright
6M ago
BCAB
BioAtla Reports Q3 2024 Financial Results and Clinical Advances
PremiumCompany Announcements
BioAtla Reports Q3 2024 Financial Results and Clinical Advances
6M ago
BCAB
BioAtla reports Q3 EPS (22c), consensus (36c)
PremiumThe Fly
BioAtla reports Q3 EPS (22c), consensus (36c)
6M ago
BCAB
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
PremiumThe Fly
BioAtla, Context Therapeutics enter exclusive license agreement for BA3362
7M ago
BCAB
CNTX
BioAtla presented poster of Phase 2 trial data at ESMO meeting
PremiumThe FlyBioAtla presented poster of Phase 2 trial data at ESMO meeting
8M ago
BCAB
BioAtla rallies after Burry’s Scion discloses new stake
Premium
The Fly
BioAtla rallies after Burry’s Scion discloses new stake
9M ago
BCAB
BioAtla management to meet virtually with BTIG
Premium
The Fly
BioAtla management to meet virtually with BTIG
9M ago
BCAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >